DT
Precision Bio
DTIL·NASDAQDurham NCFounded 2006180 employees
Micro CapbiotechPublicOncologyGenetic Medicine
Platform: ARCUS Edit
Market Cap
$0.12B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (DTIL)
Loading DTIL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Kemalemzoparlimab | DTI-7975 | Phase 2 | 2 | WEE1 | Pompe | ||
| Nidafutibatinib | DTI-3343 | NDA/BLA | 1 | EZH2 | IgANAsthma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)